Dr Reddy’s kicks off India big pharma earnings with narrow profit miss
(Reuters) -Indian generic drugs maker Dr Reddy’s Laboratories posted a narrow miss of quarterly profit expectations on Wednesday, as it struggled with pricing pressure on drugs and stiff competition in its key North America market. The firm, one of the top three drugmakers in India by revenue, has been strengthening its consumer healthcare portfolio, which …
Dr Reddy’s kicks off India big pharma earnings with narrow profit miss Read More »









